Constitutive activity of serotonin2C receptors at G protein-independent signaling: Modulation by RNA editing and antidepressants

Molecular Pharmacology

Volumn 78, Issue 5, 2010, Pages 818-826

  Labasque, Marilyne ^a   Meffre, Julie ^a   Carrat, Gaelle ^a   Becamel, Carine ^a   Bockaert, Joël ^a   Marin, Philippe ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,5 TETRAHYDRO 5 METHYL 1 (3 PYRIDYLCARBAMOYL)PYRROLO[2,3 F]INDOLE; 6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ARRESTIN; CALMODULIN; CLOMIPRAMINE; FLUOXETINE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MESSENGER RNA; MIANSERIN; MIRTAZAPINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; SEROTONIN 2C RECEPTOR; TRAZODONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CHOROID PLEXUS; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA EDITING; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ARRESTINS; CALMODULIN; CELL LINE; CHOROID PLEXUS; DRUG INVERSE AGONISM; ENZYME ACTIVATION; GTP-BINDING PROTEINS; HUMANS; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; PHOSPHORYLATION; PROTEIN MULTIMERIZATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RNA EDITING; SEROTONIN 5-HT2 RECEPTOR AGONISTS; SEROTONIN 5-HT2 RECEPTOR ANTAGONISTS; SIGNAL TRANSDUCTION;

EID: 77958130024     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.066035     Document Type: Article

References (41)

1. Aloyo VJ, Berg KA, Spampinato U, Clarke WP, and Harvey JA (2009) Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors. Pharmacol Ther 121:160-173.
2. Ayoub MA, Damian M, Gespach C, Ferrandis E, Lavergne O, De Wever O, Banères JL, Pin JP, and Prévost GP (2009) Inhibition of heterotrimeric G protein signaling by a small molecule acting on Galpha subunit. J Biol Chem 284:29136-29145.
3. Barnes WG, Reiter E, Violin JD, Ren XR, Milligan G, and Lefkowitz RJ (2005) beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation. J Biol Chem 280:8041-8050. (Pubitemid 40349702)
4. Belcheva MM, Szù csM, Wang D, Sadee W, and Coscia CJ (2001) mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation. J Biol Chem 276:33847-33853.
5. Berg KA, Dunlop J, Sanchez T, Silva M, and Clarke WP (2008a) A conservative, single-amino acid substitution in the second cytoplasmic domain of the human serotonin2C receptor alters both ligand-dependent and -independent receptor signaling. J Pharmacol Exp Ther 324:1084-1092. (Pubitemid 351397836)
6. Berg KA, Harvey JA, Spampinato U, and Clarke WP (2008b) Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression. Prog Brain Res 172:287-305.
7. Birukova AA, Birukov KG, Smurova K, Adyshev D, Kaibuchi K, Alieva I, Garcia JG, and Verin AD (2004) Novel role of microtubules in thrombin-induced endothelial barrier dysfunction. FASEB J 18:1879-1890. (Pubitemid 39602273)
8. Boldrini M, Underwood MD, Hen R, Rosoklija GB, Dwork AJ, John Mann J, and Arango V (2009) Antidepressants increase neural progenitor cells in the human hippocampus. Neuropsychopharmacology 34:2376-2389.
9. Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E, and Emeson RB (1997) Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387:303-308. (Pubitemid 27220768)
10. Chanrion B, Mannoury la Cour C, Gavarini S, Seimandi M, Vincent L, Pujol JF, Bockaert J, Marin P, and Millan MJ (2008) Inverse agonist and neutral antagonist actions of antidepressants at recombinant and native 5-hydroxytryptamine2C receptors: differential modulation of cell surface expression and signal transduction. Mol Pharmacol 73:748-757.
11. De Deurwaerdère P, Navailles S, Berg KA, Clarke WP, and Spampinato U (2004) Constitutive activity of the serotonin2C receptor inhibits in vivo dopamine release in the rat striatum and nucleus accumbens. J Neurosci 24:3235-3241. (Pubitemid 38451889)
12. Della Rocca GJ, Mukhin YV, Garnovskaya MN, Daaka Y, Clark GJ, Luttrell LM, Lefkowitz RJ, and Raymond JR (1999) Serotonin 5-HT1A receptor-mediated Erk activation requires calcium/calmodulin-dependent receptor endocytosis. J Biol Chem 274:4749-4753.
13. Di Giovanni G, Di Matteo V, Pierucci M, Benigno A, and Esposito E (2006) Central serotonin2C receptor: from physiology to pathology. Curr Top Med Chem 6:1909-1925. (Pubitemid 44524469)
14. Englander MT, Dulawa SC, Bhansali P, and Schmauss C (2005) How stress and fluoxetine modulate serotonin 2C receptor pre-mRNA editing. J Neurosci 25:648-651.
15. Esterle TM and Sanders-Bush E (1992) Serotonin agonists increase transferrin levels via activation of 5-HT1C receptors in choroid plexus epithelium. J Neurosci 12:4775-4782.
16. Gavarini S, Bécamel C, Altier C, Lory P, Poncet J, Wijnholds J, Bockaert J, and Marin P (2006) Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability. Mol Biol Cell 17:4619-4631. (Pubitemid 44665733)
17. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, et al. (2006) Distinct beta-arrestin- and G protein-dependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281:10856-10864. (Pubitemid 43855508)
18. Giorgetti M and Tecott LH (2004) Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems. Eur J Pharmacol 488:1-9. (Pubitemid 38388517)
19. Gurevich I, Tamir H, Arango V, Dwork AJ, Mann JJ, and Schmauss C (2002) Altered editing of serotonin 2C receptor pre-mRNA in the prefrontal cortex of depressed suicide victims. Neuron 34:349-356. (Pubitemid 34465494)
20. Herrick-Davis K, Grinde E, and Niswender CM (1999) Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction. J Neurochem 73:1711-1717. (Pubitemid 29440175)
21. Hurley JH, Zhang S, Bye LS, Marshall MS, DePaoli-Roach AA, Guan K, Fox AP, and Yu L (2003) Insulin signaling inhibits the 5-HT2C receptor in choroid plexus via MAP kinase. BMC Neurosci 4:10. (Pubitemid 38729169)
22. Iwamoto K and Kato T (2003) RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders. Neurosci Lett 346:169-172. (Pubitemid 36829288)
23. Iwamoto K, Nakatani N, Bundo M, Yoshikawa T, and Kato T (2005) Altered RNA editing of serotonin 2C receptor in a rat model of depression. Neurosci Res 53:69-76. (Pubitemid 41073729)
24. Kara E, Crépieux P, Gauthier C, Martinat N, Piketty V, Guillou F, and Reiter E (2006) A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Mol Endocrinol 20:3014-3026. (Pubitemid 44833552)
25. Labasque M, Reiter E, Becamel C, Bockaert J, and Marin P (2008) Physical interaction of calmodulin with the 5-hydroxytryptamine2C receptor C-terminus is essential for G protein-independent, arrestin-dependent receptor signaling. Mol Biol Cell 19:4640-4650.
26. Leggio GM, Cathala A, Neny M, Rouge-Pont F, Drago F, Piazza PV, and Spampinato U (2009) In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist. J Neurochem 111:614-623.
27. Marazziti D, Rossi A, Giannaccini G, Zavaglia KM, Dell'Osso L, Lucacchini A, and Cassano GB (1999) Distribution and characterization of [3H]mesulergine binding in human brain postmortem. Eur Neuropsychopharmacol 10:21-26.
28. Marion S, Oakley RH, Kim KM, Caron MG, and Barak LS (2006) A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem 281:2932-2938. (Pubitemid 43845759)
29. Marion S, Weiner DM, and Caron MG (2004) RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem 279:2945-2954. (Pubitemid 38114287)
30. McGrew L, Chang MS, and Sanders-Bush E (2002) Phospholipase D activation by endogenous 5-hydroxytryptamine 2C receptors is mediated by Galpha13 and pertussis toxin-insensitive Gbetagamma subunits. Mol Pharmacol 62:1339-1343. (Pubitemid 35403828)
31. Millan MJ (2005) Serotonin 5-HT2C receptors as a target for the treatment of depressive and anxious states: focus on novel therapeutic strategies. Therapie 60:441-460.
32. Millan MJ (2006) Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 110:135-370.
33. Navailles S, Moison D, Ryczko D, and Spampinato U (2006) Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors. J Neurochem 99:1311-1319. (Pubitemid 44655294)
34. Niswender CM, Copeland SC, Herrick-Davis K, Emeson RB, and Sanders-Bush E (1999) RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem 274:9472-9478.
35. Niswender CM, Herrick-Davis K, Dilley GE, Meltzer HY, Overholser JC, Stockmeier CA, Emeson RB, and Sanders-Bush E (2001) RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24:478-491. (Pubitemid 32244309)
36. Peng CH, Chiou SH, Chen SJ, Chou YC, Ku HH, Cheng CK, Yen CJ, Tsai TH, Chang YL, and Kao CL (2008) Neuroprotection by imipramine against lipopolysaccharide-induced apoptosis in hippocampus-derived neural stem cells mediated by activation of BDNF and the MAPK pathway. Eur Neuropsychopharmacol 18:128-140.
37. Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, and Lefkowitz RJ (2006) beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem 281:1261-1273.
38. Speake T, Kibble JD, and Brown PD (2004) Kv1.1 and Kv1.3 channels contribute to the delayed-rectifying K+ conductance in rat choroid plexus epithelial cells. Am J Physiol Cell Physiol 286:C611-C620. (Pubitemid 38292668)
39. Werry TD, Gregory KJ, Sexton PM, and Christopoulos A (2005) Characterization of serotonin 5-HT2C receptor signaling to extracellular signal-regulated kinases 1 and 2. J Neurochem 93:1603-1615. (Pubitemid 40853284)
40. Werry TD, Loiacono R, Sexton PM, and Christopoulos A (2008a) RNA editing of the serotonin 5HT2C receptor and its effects on cell signalling, pharmacology and brain function. Pharmacol Ther 119:7-23.
41. Werry TD, Stewart GD, Crouch MF, Watts A, Sexton PM, and Christopoulos A (2008b) Pharmacology of 5HT(2C) receptor-mediated ERK1/2 phosphorylation: agonist-specific activation pathways and the impact of RNA editing. Biochem Pharmacol 76:1276-1287.